Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New galectin-1/galectin-3 inhibitors identified at Galecto Biotech

Feb. 1, 2021

INCB-001158 plus chemotherapy shows promise for treating advanced biliary tract cancer

Feb. 1, 2021

Medshine Discovery patents multitargeted inhibitors of IRAK-4 and BTK

Feb. 1, 2021

New MAP4K1 inhibitors discovered at Guangdong Newopp Biopharmaceuticals

Feb. 1, 2021

Nanjing Zhengxiang Pharmaceuticals divulges new MAP4K1 inhibitors

Feb. 1, 2021

Sapience Therapeutics divulges BCL9 mimetic peptides for cancer

Jan. 29, 2021

Idorsia Pharmaceuticals presents IDO1 and TDO inhibitors

Jan. 29, 2021

Positive GLP toxicology study results presented for CBX-12

Jan. 29, 2021

Few-shot learning enhances biomarker identification

Jan. 29, 2021

Chinese investigators describe new KRAS mutant inhibitors

Jan. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...